Research Article
Pre- and Postoperative Health Status of Patients with Nonfunctioning and Secretory Pituitary Adenomas and an Analysis of Related Factors
Table 1
General data of the patients with pituitary adenomas.
| | | Patients with pituitary adenomas |
| | Male, n (%) | 118/41.4% | | Age (years) | 43.7 ± 14.4 | | Body mass index (kg/m2) | 25.8 ± 4.3 | | Score of anxiety | 41.4 ± 8.4 | | Score of depression | 46.3 ± 10.5 | | Score of disease stigma | 35.6 ± 14.0 | | GH of patients with GH-secreting adenomas (ng/ml) | 10.2 (6.2, 31.6) | | IGF-1 of patients with GH-secreting adenomas (ng/ml) | 827.0 (636.0, 1030.0) | | Serum cortisol of patients with ACTH-secreting adenomas (μg/dl) | 30.8 (18.1, 37.4) | | Serum ACTH of patients with ACTH-secreting adenomas (pg/ml) | 77.6 (45.6, 114.8) | | 24 h UFC of patients with ACTH-secreting adenomas (μg) | 519.2 (284.3, 743.9) | | Recurrent tumor, n (%) | 62/21.8% | | Macroadenomas, n (%) | 203/71.2% | | Largest diameter of the tumor (cm) | 1.6 (0.6, 4.3) | | Invasiveness tumor (Knosp >2), n (%) | 134/47.0% | | Visual abnormalities, n (%) | 46/16.1% | | Unmarried, n (%) | 45/15.8% | | Unemployment, n (%) | 139/48.8% | | Period of education (years) | 12.3 ± 4.1 | | Previous medical history, n (%) | 128/44.9% |
|
|
GH = growth hormone; IGF-1 = insulin-like growth factor; ACTH = adrenocorticotropic hormone; UFC = urine free cortisol.
|
